FindTrial
Sign In

A single-center retrospective study of repeated pulses of methylprednisolone combined with mycophenolate mofetil in the treatment of children with systemic lupus erythematosus

The efficacy and safety of methylprednisolone repeated pulses therapy combined with mycophenolate mofetil: results from a retrospective case series study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200062891
Enrollment
Unknown
Registered
2022-08-22
Start date
2022-08-12
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Systemic lupus erythematosus

Interventions

Case series:NA

Sponsors

The First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 16 Years

Inclusion criteria

Inclusion criteria: 1. Inclusion criteria were patients diagnosed according to the revised 1997 classification criteria of American College of Rheumatology; 2. Aged younger than 16 years at diagnosis; 3. Treatment regimen was MP repeated pluse combined with MMF; 4. Followed-up for at least 48 month with no loss or missed follow-up.

Exclusion criteria

Exclusion criteria: No.

Design outcomes

Primary

MeasureTime frame
efficacy evaluation indicators (disease activity, flares);safety evaluation indicators (blood pressure, height, body mass index, intraocular pressure, bone mineral density, fasting blood glucose, serum triglyceride, infections);—

Secondary

MeasureTime frame
clinical features;demographic data;—

Countries

China

Contacts

Public ContactSirui Yang

The First Hospital of Jilin University

sryang@jlu.edu.cn+86 431 88783747

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026